Transcripts

Cellectar Biosciences (CLRB) earnings call transcripts

Earnings call transcripts for Cellectar Biosciences, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as a shift from clinical validation toward execution, with site activation underway and financing intended to carry the WM program toward approval.

    Aug 13, 2026Positive0.67